Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00322179 · ClinicalTrials.gov registry record
Microarray Analysis of IFN-Induced Gene Expression in Obese and Non-Obese Patients With Chronic Hepatitis C
A clinical trial, sponsored by Palo Alto Veterans Institute for Research.
- Completed
- Registry status
- 22
- Enrollment target
NCT00322179 is a clinical trial that has completed, run by Palo Alto Veterans Institute for Research. The registered enrollment target is 22 participants.
The verdict
NCT00322179 has completed, sponsored by Palo Alto Veterans Institute for Research.
- COMPLETED
- Registry status
- 22 participants
- Enrollment target
Study Summary
The response rate to interferon-based anti-viral therapy for chronic hepatitis C is lower in patients who are obese. However, it is not clear whether this is related to suboptimal dosing of the medication or alterated response in obese patients. Alterated immune response had been reported in obese patients. The goal of current study is to determine the immune response to interferon in obese compared to non-obese chronic hepatitis C in an tissue culture system.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2005-11 |
| Est. Completion | 2008-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00322179
The ClinicalTrials.gov registry entry for NCT00322179 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Palo Alto Veterans Institute for Research, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00322179 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00322179 about?
NCT00322179 is a clinical study titled "Microarray Analysis of IFN-Induced Gene Expression in Obese and Non-Obese Patients With Chronic Hepatitis C". The response rate to interferon-based anti-viral therapy for chronic hepatitis C is lower in patients who are obese. However, it is not clear whether this is related to suboptimal dosing of the medication or alterated response in obese patients. Alterated immune response had been reported in obese p...
What is the current status of trial NCT00322179?
This trial is currently completed. The enrollment target is 22 participants. The study started on 2005-11. Estimated completion is 2008-11.
Who is sponsoring clinical trial NCT00322179?
This trial is sponsored by Palo Alto Veterans Institute for Research, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.